BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9448024)

  • 21. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP.
    Azeem N; Gostout CJ; Knipschield M; Baron TH
    Gastrointest Endosc; 2014 May; 79(5):773-779.e2. PubMed ID: 24206748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
    Layfield LJ; Cramer H
    Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation.
    Chung YE; Kim MJ; Park YN; Choi JY; Pyo JY; Kim YC; Cho HJ; Kim KA; Choi SY
    Radiographics; 2009; 29(3):683-700. PubMed ID: 19448110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumor grading of the hepatobiliary system].
    Jütte H; Tannapfel A
    Pathologe; 2016 Jul; 37(4):299-303. PubMed ID: 27342594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma.
    Hasebe T; Sakamoto M; Mukai K; Kawano N; Konishi M; Ryu M; Fukamachi S; Hirohashi S
    Virchows Arch; 1995; 426(2):209-13. PubMed ID: 7757293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.
    Lim JH; Zen Y; Jang KT; Kim YK; Nakanuma Y
    AJR Am J Roentgenol; 2011 Nov; 197(5):1111-20. PubMed ID: 22021503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
    Torbenson M; Yeh MM; Abraham SC
    Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H; Schramm C
    Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic observations of intrahepatic peribiliary glands in 1,000 consecutive autopsy livers: IV. Hyperplasia of intramural and extramural glands.
    Terada T; Nakanuma Y
    Hum Pathol; 1992 May; 23(5):483-90. PubMed ID: 1568745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case report. Schwannoma of both intrahepatic and extrahepatic bile ducts: a rare case.
    Madhusudhan KS; Srivastava DN; Dash NR; Gupta C; Gupta SD
    Br J Radiol; 2009 Oct; 82(982):e212-5. PubMed ID: 19759209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hilar cholangiocarcinoma (Klatskin tumor) arising from intrahepatic peribiliary glands.
    Terada T; Sasaki M; Nakanuma Y; Takeda Y; Masunaga T
    J Clin Gastroenterol; 1992 Jul; 15(1):79-81. PubMed ID: 1323595
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological observations of intrahepatic peribiliary glands in 1,000 consecutive autopsy livers. III. Survey of necroinflammation and cystic dilatation.
    Terada T; Nakanuma Y
    Hepatology; 1990 Nov; 12(5):1229-33. PubMed ID: 1699863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peripheral type of cholangiocarcinoma without intrahepatic bile duct dilatation].
    Sugiura N; Ohto M
    Ryoikibetsu Shokogun Shirizu; 1995; (7):498-500. PubMed ID: 8749536
    [No Abstract]   [Full Text] [Related]  

  • 37. [Damage to intra- and extrahepatic bile duct after hepatic artery embolization].
    Huang X; Huang Z; Duan W; Zhou N; Feng Y
    Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):169-72, 9. PubMed ID: 11832018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
    Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cholangiocarcinoma associated with Caroli's disease].
    Yoshikawa K; Ito A; Nishimura M; Kishima H; Ichikawa H; Akagi H; Minami M; Han N; Tsujimura T
    Gan No Rinsho; 1988 Jan; 34(1):73-80. PubMed ID: 2828714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resected case of eosinophilic cholangiopathy presenting with secondary sclerosing cholangitis.
    Miura F; Asano T; Amano H; Yoshida M; Toyota N; Wada K; Kato K; Takada T; Fukushima J; Kondo F; Takikawa H
    World J Gastroenterol; 2009 Mar; 15(11):1394-7. PubMed ID: 19294772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.